Confirmed efficacy and safety of dual therapy based in lamivudine plus a ritonavir-boosted protease inhibitor in the clinical setting

被引：0
|
作者：
Fontecha-Ortega, Maria [1 ]
Munoz-Mendoza, Vanessa [2 ]
Gomez, Cristina [3 ]
Sanchez-Conde, Matilde [3 ]
Angel Rodriguez, Miguel [3 ]
Jesus Vivancos, Maria [3 ]
Luis Casado, Jose [3 ]
机构：
[1] Hosp Getafe, Internal Med, Getafe, Spain
[2] Hosp Obispo Polanco, Internal Med, Teruel, Spain
[3] Hosp Ramon & Cajal, Infect Dis, Madrid, Spain
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P103
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patients
    Squires, Kathleen E.
    Young, Benjamin
    DeJesus, Edwin
    Bellos, Nicholaos
    Murphy, Daniel
    Zhao, Henry H.
    Patel, Lisa G.
    Ross, Lisa L.
    Wannamaker, Paul G.
    Shaefer, Mark S.
    AIDS, 2010, 24 (13) : 2019 - 2027
  • [22] Safety and Efficacy of a 36-Week Induction Regimen of Abacavir/Lamivudine and Ritonavir-Boosted Atazanavir in HIV-Infected Patients
    Squires, Kathleen E.
    Young, Benjamin
    DeJesus, Edwin
    Bellos, Nicholas
    Murphy, Daniel
    Sutherland-Phillips, Denise H.
    Zhao, Henry H.
    Patel, Lisa G.
    Ross, Lisa L.
    Wannamaker, Paul G.
    Shaefer, Mark S.
    HIV CLINICAL TRIALS, 2010, 11 (02): : 69 - 79
  • [23] Efficacy and safety of once-daily ritonavir-boosted darunavir and abacavir/lamivudine for treatment-naive patients: a pilot study
    Nishijima, Takeshi
    Tsukada, Kunihisa
    Teruya, Katsuji
    Gatanaga, Hiroyuki
    Kikuchi, Yoshimi
    Oka, Shinichi
    AIDS, 2012, 26 (05) : 649 - 651
  • [24] Darunavir/cobicistat as antiretroviral treatment simplification strategy in patients with stable monotherapy with ritonavir-boosted protease inhibitors in the clinical setting
    Ramon Santos, Jose
    Pelaez Ibanez, Pablo
    Bravo, Isabel
    Maria Llibre, Josep
    Paredes, Roger
    Clotet, Bonaventura
    Molto, Jose
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [25] Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity
    Casado, Jose L.
    Banon, Sara
    Rodriguez, Miguel A.
    Santiuste, Carmen
    Perez-Elias, Maria J.
    Moreno, Ana
    Moreno, Santiago
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (02) : 630 - 632
  • [26] Daily dosing of tacrolimus in patients treated with HIV-1 therapy containing a ritonavir-boosted protease inhibitor or raltegravir
    Bickel, Markus
    Anadol, Evrim
    Vogel, Martin
    Hofmann, Wolf Peter
    von Hentig, Nils
    Kuetscher, Johannes
    Kurowski, Michael
    Moench, Christian
    Lennemann, Tessa
    Lutz, Thomas
    Bechstein, Wolf Otto
    Brodt, Hans Reinhard
    Rockstroh, Juergen
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (05) : 999 - 1004
  • [27] Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting
    Macias, J.
    Recio, E.
    Marquez, M.
    Garcia, C.
    Jimenez, P.
    Merino, D.
    Munoz, L.
    Pasquau, J.
    Ojeda, G.
    Bancalero, P.
    Chueca, N.
    Pineda, J. A.
    HIV MEDICINE, 2014, 15 (07) : 417 - 424
  • [28] Dual Raltegravir-Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
    Calza, Leonardo
    Danese, Ilaria
    Magistrelli, Eleonora
    Colangeli, Vincenzo
    Manfredi, Roberto
    Bon, Isabella
    Re, Maria Carla
    Conti, Matteo
    Viale, Pierluigi
    HIV CLINICAL TRIALS, 2016, 17 (01): : 38 - 47
  • [29] Treatment of HIV-positive patients with lamivudine plus boosted protease inhibitor in a real-world setting
    Cheng, Chien-Yu
    Cheng, Shu-Hsing
    Chang, Shu-Yin
    Lin, Mei-Hui
    Ku, Shin-Yen
    Shieh, Hui-Ting
    Sun, Na-Lee
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [30] A meta-analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir-boosted protease inhibitor maintenance therapy in HIV-infected adults with established virological suppression after induction
    Baril, J.
    Conway, B.
    Giguere, P.
    Ferko, N.
    Hollmann, S.
    Angel, J. B.
    HIV MEDICINE, 2014, 15 (05) : 301 - 310
12345